# Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La Réunion

> **NCT06928753** · PHASE4 · RECRUITING · sponsor: **Centre Hospitalier Universitaire de la Réunion** · enrollment: 1800 (estimated)

## Conditions studied

- Chikungunya Virus Infection

## Interventions

- **BIOLOGICAL:** IXCHIQ

## Key facts

- **NCT ID:** NCT06928753
- **Lead sponsor:** Centre Hospitalier Universitaire de la Réunion
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-18
- **Primary completion:** 2026-04
- **Final completion:** 2026-10
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06928753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06928753, "Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La Réunion". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06928753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*